Urology · Full case

Urinary Incontinence (Female)

NICE NG123

50%Women affected at some point in life

3 monthsConservative Rx before considering surgery

3 monthsSupervised PFMT trial minimum (NICE NG123)

3×/dayPFMT sets per day (8–12 contractions)

1.5–2LOptimal daily fluid intake

6–8Normal voids/day; >8 = frequency

6 wksBladder training minimum (NICE NG123)

4mgTolterodine XL OD (or 2mg BD) — one option; choose antimuscarinic by local formulary

📋 Clinical Stem — Female Urinary Incontinence

A woman presents with urinary leakage — to seek diagnosis, explanation, and a management plan.

"A 52-year-old woman attends her GP with an 18-month history of urinary leakage. She reports leakage when coughing, sneezing, and running, as well as occasional urgency to pass urine with leaking before reaching the toilet. She had two vaginal deliveries. BMI 29. She drinks 3–4 cups of coffee daily. She is embarrassed and has been avoiding exercise and social events. She has not mentioned this to her GP before."

Urinary incontinence is significantly underreported due to embarrassment. GPs must create psychological safety to explore the symptom fully. NICE NG123 prioritises conservative treatment first: supervised pelvic floor muscle training for at least 3 months for stress incontinence, and bladder training for at least 6 weeks for urgency incontinence before drug treatment.

Scenario A — Stress incontinence (SUI) Leakage with exertion, cough, sneezing; no urgency; post-partum or post-menopausal; first-line PFMT; refer if no response at 3 months.

Scenario B — Urgency incontinence (OAB) Urgency, frequency, nocturia, leakage before reaching toilet; bladder retraining + antimuscarinics; rule out UTI and haematuria.

Scenario C — Mixed incontinence Features of both SUI and OAB; treat the predominant symptom first; PFMT + bladder retraining; consider dual pharmacotherapy.

Scenario D — Post-menopausal with GSM Urgency, frequency, recurrent UTIs; oestrogen-deficient urethra and bladder trigone; vaginal oestrogen as primary treatment.

Scenario E — Overflow incontinence Dribbling; poor stream; post-void residual; associated with neurological disease, medications, or pelvic mass; acute retention needs catheterisation and same-day assessment, chronic incomplete emptying needs prompt PVR and referral depending on findings.

Key variables to adapt Type of incontinence (SUI/OAB/mixed/overflow), parity, BMI, post-menopausal status, fluid intake, medications, neurological disease, pelvic organ prolapse, previous pelvic surgery.

Steps:

Step 1

History Taking — Open Question First · Symptom Characterisation · ICE · Psychosocial Impact

▲collapse

Urinary incontinence is massively underreported. Up to 50% of affected women never disclose symptoms to a healthcare professional due to embarrassment, fatalism ("it's just part of getting older"), or not knowing that effective treatments exist. The GP must create psychological safety before exploring the symptom and must not normalise incontinence as inevitable.

🎓 SCA opener — normalise before data-gathering

"This is something a lot of women deal with but don't always feel comfortable talking about — so thank you for bringing it up. Before I ask you lots of questions, can you tell me in your own words what's been happening and how it's been affecting your life?"

Normalisation at the start prevents the patient from minimising her symptoms. The impact on quality of life (QoL) drives the clinical urgency, not the volume of leakage alone.

1A — Symptom characterisation: type, trigger, severity, impact

Question	Why it matters	Changes what?
🟢 OPEN QUESTION first"Tell me in your own words what's been happening and how it's been affecting you."	QoL impact drives the clinical urgency. A woman with small leakage but complete social withdrawal needs urgent treatment. A woman with large leakage who is not bothered requires a different intensity of response.Patient-reported impact, not volume of leakage, determines treatment priority.	QoL impactTreatment urgency
Type: stress vs urgency triggers"Does the leakage happen when you cough, sneeze, laugh, or exercise? Or do you get a sudden desperate urge to pass urine first?"	Stress urinary incontinence (SUI): leakage with physical exertion (cough, sneeze, exercise). Urgency incontinence (OAB): urgency +/— leakage before reaching toilet. Mixed: both. The type determines the first-line treatment.SUI: PFMT first-line. OAB: bladder retraining + antimuscarinics. Mixed: treat predominant symptom first.	DDxRx
Frequency and nocturia"How many times do you pass urine in the day? Do you get up at night to pass urine?"	Normal voiding: 6–8 times/day; 0–1 at night. Frequency >8/day or nocturia ≥2 suggests OAB. Polyuria (frequency with large volumes) may indicate diabetes or DI rather than OAB.Distinguish OAB urgency/frequency from DM (polyuria), UTI (dysuria + frequency), or fluid overload.	DDx
Fluid intake"What do you drink in a day and how much? Any caffeine, alcohol, or fizzy drinks?"	Caffeine, alcohol, and fizzy drinks are bladder irritants that exacerbate OAB symptoms. Fluid intake too low (below 1.5L) concentrates urine and worsens urgency. Fluid restriction is a common but counterproductive patient strategy.Advise 1.5–2L non-caffeinated fluid/day; reducing caffeine alone can halve OAB symptoms in some women.	Lifestyle Rx
Haematuria"Have you noticed any blood in your urine at any point?"	Haematuria + urinary symptoms = bladder cancer / bladder stone / renal pathology until proven otherwise. Must be investigated urgently regardless of incontinence type.NICE NG12 (updated April 2026): suspected cancer pathway referral for bladder cancer if aged 45 or over with unexplained visible haematuria without UTI (or persisting/recurring after UTI treatment), or aged 60 or over with unexplained non-visible haematuria plus dysuria or raised white cell count.	Red flagReferral
Prolapse symptoms"Do you notice any bulging or heaviness in your vaginal area? Any dragging sensation?"	Pelvic organ prolapse (POP) coexists with SUI in 30–50% of affected women and changes the surgical management pathway. Symptomatic cystocele may cause both SUI and incomplete bladder emptying.POP referral: urogynaeological surgical pathway rather than pure incontinence pathway.	ReferralDDx
Obstetric and surgical history"How many pregnancies have you had? Any instrumental deliveries? Any previous pelvic surgery?"	Vaginal delivery (especially instrumental) causes pudendal nerve and sphincter damage. Previous pelvic surgery (hysterectomy, incontinence repair) changes the treatment pathway and risk profile for further surgery.Two or more vaginal deliveries: 3× higher SUI risk. Forceps delivery: significantly higher risk of sphincter damage.	DDxSurgical pathway
Current medications"Are you on any regular medications? Any diuretics, ACE inhibitors, alpha-blockers?"	Diuretics cause frequency and urgency. ACE inhibitors cause cough which worsens SUI. Alpha-blockers cause urethral relaxation (overflow/SUI). Opiates cause urinary retention. Antipsychotics and TCAs affect bladder tone.Review and modify causative medications before initiating bladder-specific treatment.	Medication review
Post-menopausal and hormonal status"Have you gone through the menopause? Are you on any HRT?"	Oestrogen deficiency causes urethral atrophy, reduced urethral closure pressure, and bladder trigone hypersensitivity. GSM-related incontinence (post-menopausal urgency, frequency, recurrent UTIs) responds to vaginal oestrogen.Systemic HRT does not improve incontinence; local vaginal oestrogen is specific treatment for GSM.	Vaginal oestrogen

1B — Red flags: must not miss

🚨

Red Flags in female urinary incontinence

Red flag	Why dangerous	Action
Haematuria (visible or non-visible) + urinary symptoms	Bladder cancer presents with painless haematuria. NICE NG12 (updated April 2026): suspected cancer pathway referral for bladder cancer if aged 45 or over with unexplained visible haematuria without UTI (or persisting/recurring after UTI treatment), or aged 60 or over with unexplained non-visible haematuria plus dysuria or raised white cell count.	Urology suspected cancer pathway referral if NG12 criteria met; otherwise urological/renal assessment
Acute urinary retention (no urine output despite full bladder)	Overflow incontinence secondary to urinary retention. Causes: pelvic mass, neurological disease, drug-induced. Needs catheterisation and same-day assessment.	A&E / same day
Neurological symptoms (new saddle anaesthesia, lower limb weakness)	Cauda equina syndrome. New onset incontinence + bilateral leg weakness + saddle anaesthesia = emergency MRI spine + neurosurgery.	999 emergency
New onset incontinence with weight loss, night sweats, rectal bleeding	Pelvic malignancy (bladder, colorectal, cervical, ovarian). These systemic symptoms alongside new incontinence require urgent investigation.	Urgent USS / suspected cancer pathway referral
Post-void dribbling + straining to void + poor stream	Overflow incontinence from urethral obstruction or neurological detrusor underactivity. Measure the post-void residual and interpret it in clinical context (no universal NICE cut-off); persistent significant residual or voiding dysfunction → refer.	Post-void USS; urology

🛡️

Safeguarding Considerations

👴 Domestic abuse and urinary incontinence

Sexual violence and perineal trauma can cause urinary symptoms including urinary fistula (continuous leakage)
Women with domestic abuse histories may have delayed presentation
Vesico-vaginal fistula after traumatic delivery or assault = urgent urogynaeological referral

🧠 Mental health impact

Severe incontinence causes social isolation, depression, and withdrawal from work and relationships
Screen with PHQ-9 if QoL is severely impaired
Incontinence-related depression responds to treatment of the incontinence, not just antidepressants

👤 Older women and falls risk

Nocturia in older women significantly increases falls and hip fracture risk
Urgency incontinence in nursing home residents is a major safety issue
Anticholinergic burden in older women: review cognition and falls risk. The MHRA public assessment report (27 July 2026) found insufficient evidence of a direct causal link between bladder anticholinergics and dementia, though a small risk cannot be excluded. Mirabegron is an option if antimuscarinics are contraindicated, ineffective or not tolerated (NICE TA290)

🕊 Carer and dignity issues

Women in care settings may have incontinence managed with pads when treatable causes have never been assessed
Ensure each patient has had at least one formal assessment of their incontinence type
Dignity in incontinence care is a CQC and safeguarding issue in care homes

If trauma-related fistula suspected or domestic abuse identified: follow safeguarding protocols; refer to urogynaeology urgently for fistula; document DASH risk assessment for domestic abuse.

1C — ICE & Psychosocial

💭 Ideas

"What do you think is causing the leakage? Have you been told anything about why this might be happening?"

Many women believe incontinence is an inevitable consequence of childbirth or ageing. Correcting this fatalistic belief is the first therapeutic step — most types of incontinence are highly treatable.

😟 Concerns

"What's your biggest worry about this — is it about the leakage itself, how it's affecting your daily life, or whether treatment would involve surgery?"

Common concerns: fear of surgery (often unnecessary), embarrassment about pads/smell, fear that it will worsen. Unaddressed concern about surgery stops women engaging with effective conservative treatment.

🔇 Expectations

"What would make this appointment really useful for you? Are you looking for a diagnosis, exercises to try, or more information about what the options are?"

Some women want immediate referral to a specialist; others want to try conservative measures first. Without asking, the GP may offer the wrong starting point.

👴 Social withdrawal and isolation

Incontinence causes women to avoid exercise, socialising, travel, and work. This secondary social withdrawal significantly amplifies psychological morbidity. Treatment of the incontinence alone markedly improves these downstream consequences.

"Has this stopped you from doing things you'd normally do — exercise, going out, travel? I ask because that really matters to the treatment plan."

💉 Relationship and intimacy

Incontinence during sexual intercourse (coital incontinence) affects up to 30% of women with SUI or OAB. It is almost never volunteered without direct questioning. It causes significant relationship strain and sexual avoidance.

"Has the leakage been affecting your sex life or intimacy at all? I ask everyone because it's very common and there are very effective treatments for it."

📌 Pad use and cost

Many women manage incontinence with sanitary or incontinence pads for years without seeking help. The cost, inconvenience, and skin effects of long-term pad use are a hidden burden. Effective treatment saves both money and dignity.

"Are you using pads regularly? How many per day? That gives me an idea of the severity and also what we can realistically aim to achieve with treatment."

🧠 Fatalism: "it's just part of getting old"

Fatalism about incontinence prevents help-seeking and reduces treatment uptake. 70–80% of women with SUI significantly improve or are cured with PFMT alone. This is a highly treatable condition if patients are given accurate information.

"I want to reassure you that this is not something you have to just put up with — the treatments are effective, and most women see a real improvement."

🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills

Key phrases

"This is something a lot of women deal with but don't always feel comfortable talking about — thank you for bringing it up."

"Does the leakage happen when you cough or sneeze, or do you get a sudden desperate urge first — or both?"

"Has there been any blood in your urine at any point?"

"This doesn't have to be something you just put up with — the treatments are very effective."

Deductions

Not characterising type (SUI vs OAB vs mixed) — treatment pathway wrong
Missing haematuria — red flag not addressed
Prescribing antimuscarinics without trying bladder retraining first (NICE NG123)
Normalising incontinence as "just part of ageing"
Not asking about QoL impact

🔴 Red

Type not characterised • haematuria missed • antimuscarinics without conservative Rx • normalised as ageing • no ICE

🟠 Amber

Type characterised • haematuria asked • conservative Rx mentioned • QoL impact not fully explored • ICE superficial

🟢 Green

Open Q • type (SUI/OAB/mixed) • haematuria • fluid intake • QoL impact • ICE all 3 • normalised empathetically • not normalised as inevitable

Step 2

Triage Engine

▲collapse

🔴 Emergency

999 / Same Day

Immediate

Acute urinary retentionNo urine output despite full bladder; painful; catheterisation + same-day urology or A&E
Cauda equina syndromeNew incontinence + saddle anaesthesia + bilateral lower limb weakness → 999 + emergency MRI

🟠 Urgent

Suspected cancer pathway referral / Urology

Days to weeks

Haematuria (visible ≥45, or non-visible ≥60 with dysuria or raised WCC)Urology suspected cancer pathway referral; NICE NG12; visible haematuria under 45 still needs urological/renal assessment
Suspected overflow incontinencePost-void residual, interpreted in clinical context; refer if persistent significant residual or voiding dysfunction
Incontinence + new neurological symptomsNew bladder or bowel change with new neurology → 999 / emergency assessment (cauda equina); otherwise urgent neurology

🟢 Routine

GP-managed

Planned

SUI: pelvic floor muscle training (PFMT)First-line; minimum 3 months; refer if no improvement
OAB: bladder retraining + lifestyle6–8 weeks minimum; antimuscarinics second-line
Post-menopausal GSM-related incontinenceVaginal oestrogen first-line; PFMT + bladder retraining alongside
Conservative measures failedRefer to continence physiotherapy or urogynaecology

🎓 SCA Checkpoint — Step 2Tasks

🔴 Red

Haematuria not escalated • cauda equina not recognised • overflow not considered

🟢 Green

Haematuria = suspected cancer pathway referral • cauda equina screened • retention recognised • conservative Rx threshold correct

Step 3

Do I Need This Examination?

▲collapse

Examination	Why	Finding that changes management	Changes?
Pelvic examination (vulva, vagina, cervix)	Assess for pelvic organ prolapse (cystocele, rectocele, uterine prolapse); vaginal atrophy (GSM); perineal scarring; fistula. Prolapse changes the surgical pathway.Visible or symptomatic prolapse, particularly at or beyond the vaginal introitus, changes management to urogynaecological referral (POP-Q staging is done in specialist care).	Visible or symptomatic prolapse = urogynaecology referral; vaginal atrophy = vaginal oestrogen; fistula = urgent urogynaeology	YES — Referral route
Abdominal examination	Palpable bladder suggests urinary retention. Pelvic mass may cause urethral compression. Ascites suggests malignancy.Palpable bladder post-void = retention → catheterisation + USS post-void residual.	Palpable bladder = retention; pelvic or abdominal mass not obviously fibroids = gynaecology suspected cancer pathway referral (NG12)	YES — urgent if mass
Cough stress test	Demonstrates SUI objectively. In dorsal lithotomy position with full bladder: ask patient to cough; observe urethral meatus for urine loss.Positive: confirms SUI. Negative with typical history: still treat as SUI; test has variable sensitivity.	Positive = SUI confirmed; documents severity; useful for referral documentation	Context: SUI
Neurological examination (lower limbs, saddle area)	New onset incontinence with neurological symptoms: exclude cauda equina, multiple sclerosis, Parkinson's disease.Absent anal reflex + saddle anaesthesia = cauda equina emergency.	Neurological signs = urgent spinal imaging; neurourology referral	Context: new onset + neuro symptoms
BMI	BMI >35 independently worsens SUI and reduces surgical outcomes. NICE NG123: advise women with UI and BMI >30 to lose weight.Weight loss 5–10% significantly improves SUI in overweight women.	BMI ≥30 = offer or refer for weight-management support; do not delay PFMT or other treatment while waiting for weight loss	YES — surgical eligibility

🎓 SCA Checkpoint — Step 3Tasks

🔴 Red

Pelvic exam not mentioned • prolapse missed • BMI not noted for surgical planning

🟢 Green

Pelvic exam for prolapse • vaginal atrophy noted • BMI documented • neurological screen if indicated

Step 4

Do I Need This Investigation?

▲collapse

Investigation	Clinical question	Abnormal result action
Urine dipstick + MSU if positive	Is there UTI causing or contributing to urgency symptoms? Treat UTI before attributing all symptoms to OAB. UTI is the most common reversible cause of urinary urgency.	UTI symptoms + nitrites and leucocytes = MSU and treat pending culture; do not treat asymptomatic bacteriuria; reassess OAB symptoms after treatment; recurrent UTI (≥2/6m or 3/year) = MSU culture; consider vaginal oestrogen post-menopause
Post-void residual (USS bladder)	Is there incomplete bladder emptying? A significant residual, interpreted in clinical context (no universal NICE cut-off), suggests an overflow component (neurological, obstruction, or drug-induced). Missed retention presenting as overflow incontinence.	Persistent significant residual = refer urology/urogynaecology for further investigation; intermittent self-catheterisation may be needed
Bladder diary (3–5 days)	Quantifies frequency, volumes voided, fluid intake, urgency episodes and leakage events. Essential for treatment monitoring and for urogynaecology referral. NICE NG123 recommends for all women before treatment.	Frequency >8/day or nocturia ≥2 supports OAB when interpreted with fluid intake, diuretics and context; large volumes per void suggest polyuria not OAB; small volumes confirm bladder hypersensitivity
Urine culture (MSU)	Recurrent UTI in post-menopausal women often related to urethral atrophy. Identify organism and sensitivity for targeted treatment.	Recurrent culture-positive UTI = vaginal oestrogen; prophylactic antibiotics (trimethoprim or nitrofurantoin); urology if structural cause
Urodynamic testing (specialist)	Confirms OAB (detrusor overactivity) or SUI (urethral sphincter incompetence) objectively before surgery. NICE NG123: do not perform multichannel cystometry, ambulatory urodynamics or videourodynamics before starting conservative management.	Detrusor overactivity confirmed = OAB pathway; genuine stress incontinence confirmed = mid-urethral sling pathway; mixed = combined treatment
HbA1c / fasting glucose	Diabetes causes polyuria and can masquerade as OAB frequency. Glycosuria also causes bladder irritation and worsens OAB.	HbA1c ≥48 = T2DM; treat DM; frequency/nocturia may improve significantly with glycaemic control
Renal USS	Hydronephrosis suggests upper tract obstruction secondary to lower tract outflow obstruction. Renal pathology causing polyuria.	Hydronephrosis = urgent urology; chronic retention → renal impairment = emergency management

🎓 SCA Checkpoint — Step 4Tasks

🔴 Red

UTI not excluded before treating OAB • no bladder diary • overflow incontinence missed (no post-void residual)

🟢 Green

UTI dipstick • bladder diary recommended • post-void residual if overflow features • HbA1c if polyuria suspected

Step 5

Reaching a Diagnosis — Type Classification & Plain Language

▲collapse

🗣️ Explaining urinary incontinence in plain language

"There are a few different types of urinary leakage, and the type matters because the treatments are different. The one you describe — leakage when you cough or sneeze — happens because the muscles supporting the bladder have been stretched, usually by childbirth, and aren't closing tightly enough under pressure. The good news is that specific strengthening exercises can fix this in up to 70–80% of women — without surgery."

A — GP-managed (conservative Rx first)

Stress Urinary Incontinence (SUI)

Leakage with exertion, cough, sneeze. No urgency. PFMT 3 months minimum; refer if fails; mid-urethral sling if surgery needed.

Overactive Bladder (OAB) / Urgency incontinence

Urgency ± frequency ± nocturia ± urgency incontinence. Bladder retraining + lifestyle; antimuscarinics or mirabegron second-line.

Mixed incontinence

Both SUI and OAB features. Treat predominant symptom first; bladder diary guides prioritisation.

B — Specialist input needed

GSM-related incontinence

Post-menopausal: urgency, recurrent UTI, urethral atrophy. Vaginal oestrogen primary treatment. Refer if fails.

Pelvic organ prolapse + incontinence

Coexisting prolapse changes surgical pathway. Urogynaeological referral for combined management.

C — Emergency / urgent

Overflow incontinence (retention)

Continuous dribbling + poor stream + palpable bladder. Acute retention: catheterise + same-day urology or A&E; chronic incomplete emptying: prompt PVR and referral depending on findings.

Cauda equina syndrome

New incontinence + saddle anaesthesia + bilateral leg weakness. 999 emergency MRI spine + neurosurgery.

🎓 SCA Checkpoint — Step 5TasksRelating to Others

🔴 Red

Type not specified • overflow missed • cauda equina not screened • "just part of ageing" comment

🟢 Green

Type named • plain language explanation • DDx considered • 70–80% cure with PFMT mentioned • emergency recognised

Step 6

If Referral Is Needed

▲collapse

Scenario	Urgency	GP action before referral	Must NOT do
SUI: conservative Rx failed (3 months PFMT)	Routine	Document 3 months of supervised PFMT; bladder diary; BMI; exclude UTI; refer to continence physiotherapy or urogynaecology	Refer before 3 months of supervised conservative treatment (NICE NG123 threshold)
Haematuria + urinary symptoms	Suspected cancer pathway referral	Urine dipstick; MSU; USS bladder; refer to urology on the suspected cancer pathway per NICE NG12	Treat as UTI without culture; delay suspected cancer pathway referral for haematuria
Overflow incontinence / urinary retention	Same day if acute retention; prompt if chronic	Catheterise if acute retention; post-void residual USS; investigate cause (drug review, pelvic mass, neurological)	Prescribe antimuscarinics for overflow incontinence — this worsens retention
Pelvic organ prolapse + incontinence	Routine	Stage prolapse on pelvic exam; complete conservative treatment first; combined referral to urogynaeology for pelvic floor assessment and surgical planning	Refer for incontinence surgery alone without addressing prolapse — increases recurrence
OAB: pharmacological treatment failed	Routine	Document trial of at least one antimuscarinic + mirabegron; bladder diary; document QoL impact; refer to urogynaecology for botulinum toxin or sacral nerve stimulation	Prescribe antimuscarinics in older women without checking for cognitive effects and falls risk

🎓 SCA Checkpoint — Step 6Tasks

🔴 Red

Haematuria suspected cancer pathway referral not stated • antimuscarinics for overflow • surgical referral before 3 months conservative

🟢 Green

3 months conservative before referral • haematuria = suspected cancer pathway referral • overflow = A&E • prolapse addressed in surgical planning

Step 7

Management — PFMT · Bladder Retraining · Drug Cards · Monitoring · Safety-Netting

▲collapse

7A — Address expectation first

🤝

70–80% of women with SUI improve significantly with PFMT alone — surgery is rarely the first step

Validate

Thank her for raising it. Name the impact on QoL explicitly.

"Thank you for telling me — it takes courage to bring this up. I can hear how much it's been affecting your day-to-day life."

Explain

Provide the evidence. Most women do not need surgery.

"Before we think about any other options, I want to reassure you that most women — 7 or 8 out of 10 — see a real improvement with the right exercises, without needing surgery."

Agree today's plan

Start exercises today; give bladder diary; arrange follow-up.

"I'd like to go through the exercises with you now and give you a diary to keep for the next 3–5 days — that will help us track progress."

Key principle: NICE NG123: conservative treatment first — supervised PFMT for at least 3 months (stress) and bladder training for at least 6 weeks (urgency) before drug treatment; surgery only after conservative options.

7B — Conservative management: PFMT, bladder retraining, lifestyle

🏃

PFMT (Pelvic Floor)

3×/day; 8–12 contractions; at least 3 months

Mechanism

Strengthens levator ani and external urethral sphincter; increases urethral closure pressure. Re-establishes the "knack" reflex (pre-contraction before cough). Most effective for SUI; adjunct for OAB.

Practical

3 sets/day, 8–12 contractions per set, hold 6–8 seconds. NHS SQUEEZY app. Supervised physiotherapy more effective than leaflet alone. Assess at 3 months; inadequate improvement after at least 3 months of supervised PFMT → urogynaecology referral.

70–80% improvement or cure in SUI with supervised PFMT

🌞

Bladder Retraining (OAB)

Extend voiding interval by 15 min/wk; target 3–4h

Mechanism

Gradually increases bladder capacity by resisting urgency; reconditions detrusor to suppress uninhibited contractions; breaks urgency→rushing→leakage cycle.

Practical

"Freeze and squeeze" technique for urge suppression: pelvic floor contraction + distraction during urge. Increase voiding interval by 15 min/week. Minimum 6–8 weeks before adding pharmacotherapy.

75% improvement in OAB with bladder retraining alone

☕

Fluid Management

1.5–2L non-caffeinated; reduce caffeine/alcohol

Mechanism

Caffeine is a diuretic and bladder irritant; increases urgency and frequency. Over-restriction concentrates urine and worsens urgency. Carbonated drinks directly irritate bladder mucosa.

Practical

Replace caffeine (coffee, tea, cola) with water or herbal tea. Maintain 1.5–2L total fluid. Avoid drinking >200mL in 2 hours before bedtime for nocturia.

A trial of caffeine reduction reduces urgency episodes

⚖️

Weight Loss

5–10% reduces SUI significantly

Mechanism

Each BMI unit increase raises SUI risk 3–5%. Weight loss reduces intra-abdominal pressure on the bladder and pelvic floor. Improves PFMT response.

Practical

NHS Tier 2/3 weight management referral. NICE NG123: advise weight loss for women with UI or OAB who have a BMI >30.

5–10% weight loss significantly improves SUI severity

🕆

Constipation Management

Bristol type 4; avoid straining

Mechanism

Chronic straining causes pudendal nerve traction injury and weakens pelvic floor. Loaded rectum compresses urethra, worsening incomplete emptying and urgency.

Practical

Increase fibre and fluid; bulking laxative (ispaghula) if needed. Avoid Valsalva; lean forward and relax pelvic floor to empty bowel.

Treating constipation improves bladder symptoms in 30%

🕊

Smoking Cessation

Stop completely

Mechanism

Chronic smoker's cough creates repeated high-pressure bladder events, damaging pelvic floor. Nicotine is a bladder irritant worsening OAB. Smokers have higher bladder cancer risk (haematuria awareness).

Practical

NHS Stop Smoking Service referral; behavioural support plus varenicline, cytisinicline, combination NRT or a nicotine vape (NICE NG209); NRT if pregnant.

Eliminating cough reduces SUI trigger events; reduces bladder CA risk

⚙ Interactive Medication Chooser — tick the patient profile, options re-tier live against NICE NG123 / SPC

A live, topic-scoped version of the standalone Medication Chooser. The detailed reference cards below are unchanged.

7C — Drug reference cards

Tolterodine (Antimuscarinic)

Detrusitol 2mg BD; Detrusitol XL 4mg OD

✓ OAB antimuscarinic option (choose by local formulary)

OAB second-line2mg BD or 4mg XL OD

✓ Use when

OAB not controlled by bladder retraining alone after 6–8 weeks

Better CNS tolerability than oxybutynin IR; preferred over oxybutynin in older adults

✗ Avoid if

Urinary retention / significant post-void residual — antimuscarinics worsen retention

Narrow-angle glaucoma; gastric retention

Cognitive impairment in older women: prefer mirabegron; cardiac conduction defect

⚠ Side effects

Dry mouth (most common); constipation; blurred vision; cognitive impairment in elderly

🔬 Monitor

Response at 4 weeks; bladder diary; post-void residual if elderly; cognitive function in older women

💬 Counselling

"This tablet reduces the overactive bladder signals. Dry mouth is common — sip water regularly. If you find it hard to pass urine at all, stop and contact us immediately."

SCA pearl: Antimuscarinics must only be offered after conservative treatment (bladder retraining) has been tried. Prescribing without this step contradicts NICE NG123 and is a scored Tasks deduction. Never prescribe if overflow incontinence suspected.

Oxybutynin (Antimuscarinic)

Cystrin 2.5–5mg BD/TDS; oxybutynin patch (Kentera)

✓ OAB younger women (avoid elderly)

OAB second-line2.5–5mg BD–TDS; max 20mg/day

✓ Use when

OAB in younger women where cognitive side-effect profile less concerning

Oxybutynin patch: reduced systemic anticholinergic effects vs oral

✗ Avoid if

AVOID in women >65: STOPP criteria; significant cognitive impairment + falls risk

Urinary retention; narrow-angle glaucoma; gastric retention; myasthenia gravis

⚠ Side effects

Dry mouth; constipation; blurred vision; tachycardia; confusion in elderly

💬 Counselling

"This reduces the urgency by calming the bladder muscle. Dry mouth is common. If you're over 65, I would usually prefer a different medication with fewer side effects."

SCA pearl: Oxybutynin is inappropriate in women over 65 due to cognitive and falls risk (STOPP criteria). Mentioning mirabegron as the preferred alternative in older women scores a Tasks mark.

Mirabegron (Beta-3 agonist)

Betmiga 50mg OD (25mg in renal or hepatic impairment per SPC)

✓ Antimuscarinic unsuitable, ineffective or not tolerated

OAB preferred elderly50mg OD (dose per SPC)

✓ Use when

Older women (>65): NO anticholinergic burden; no cognitive effects; no retention risk

Antimuscarinic intolerance or contraindication (dry mouth, constipation, cognitive impairment)

✗ Avoid if

Severe uncontrolled hypertension (BP ≥180/110); end-stage renal disease

🔬 Monitor

BP before starting and regularly during treatment; symptom response at 4 weeks; bladder diary

💬 Counselling

"This works differently to the older bladder tablets — no dry mouth, no constipation, safer for memory. It can raise blood pressure, so we'll check it before you start and regularly while you take it."

SCA pearl: Mirabegron has no anticholinergic burden, so it is a useful option in older women; NICE TA290 recommends it when antimuscarinics are contraindicated, clinically ineffective or not tolerated. The MHRA (July 2026) found insufficient evidence of a direct causal link between bladder anticholinergics and dementia, but a small risk cannot be excluded. Mentioning this distinction in an elderly patient scores a Tasks mark.

Duloxetine (SNRI — Yentreve)

Yentreve 20–40mg BD — licensed specifically for SUI

✓ SUI if surgery declined after PFMT failed

SUI (surgery declined)20mg BD → 40mg BD after 2 weeks

✓ Use when

SUI after PFMT has failed + patient declines surgery

May also improve co-existing depression / anxiety in women with incontinence

✗ Avoid if

Uncontrolled hypertension; severe hepatic / renal impairment; MAOIs; thioridazine

High discontinuation rate due to nausea; not as effective as surgery

⚠ Side effects

Nausea (most common; improves after 4–8 weeks; take with food); dry mouth; insomnia; discontinue gradually

💬 Counselling

"This works on the nerve that controls the bladder outlet. Nausea is common at first but usually settles. It's not as effective as surgery but is a good option if you'd rather not have an operation."

SCA pearl: Duloxetine is specifically licensed for SUI as Yentreve — NOT first-line. NICE NG123: not first-line and not routinely second-line — may be offered second-line if she prefers drug treatment to surgery or is not suitable for surgery. Knowing the brand name (Yentreve) distinguishes it from antidepressant duloxetine dosing — scored knowledge.

Vaginal Oestrogen

Vagifem 10mcg pessaries; Ovestin cream; Estring ring

✓ Post-menopausal GSM-related incontinence

Post-menopausalPessary nightly 2 weeks then twice weekly

✓ Use when

Post-menopausal urgency, frequency, recurrent UTIs — GSM (urethral and trigone atrophy)

Low systemic absorption; can be continued as long as needed with regular review; in women with breast cancer involve oncology/menopause specialists

✗ Avoid if

Unexplained vaginal bleeding — investigate first

ER+ breast cancer on aromatase inhibitors: discuss with oncologist

💬 Counselling

"This very low-dose oestrogen stays in the vaginal area and restores the bladder outlet lining. It reduces urgency and recurrent infections. You can use it long-term without the risks of systemic HRT."

SCA pearl: In a post-menopausal woman with urgency incontinence and recurrent UTIs, identify GSM as the cause and offer vaginal oestrogen as primary treatment — not just a side note. This scores a Tasks mark for GSM recognition and appropriate management.

Solifenacin (Antimuscarinic)

Vesicare 5mg OD → 10mg OD

✓ OAB: once-daily dosing

OAB second-line5mg OD → 10mg OD

✓ Use when

OAB after bladder retraining; once-daily dosing improves adherence

Better tolerated than oxybutynin IR; similar efficacy to tolterodine

✗ Avoid if

Urinary retention; narrow-angle glaucoma; gastric retention

Elderly (>65): anticholinergic burden; prefer mirabegron

💬 Counselling

"This is a once-a-day tablet to help with the urgency. Dry mouth is the main side effect. If you can't pass urine properly, stop and contact us."

SCA pearl: Know the spectrum of antimuscarinics: oxybutynin (avoid elderly), tolterodine/solifenacin (safer than oxybutynin), mirabegron (preferred elderly, no anticholinergic effects). These distinctions are scored Tasks knowledge items.

7D — Follow-up schedule

4 weeks (early review)

Bladder diary review; PFMT adherence; medication side effects; dose titration; haematuria since consultation.

Bladder diaryMedication response

3 months (NICE NG123 PFMT trial)

Formal assessment of conservative treatment response. If PFMT not working: continence physiotherapy referral. If OAB not responding: add pharmacotherapy. If SUI no response: urogynaecology referral.

3-month thresholdReferral decision

6 months (sustained response)

Pad count; frequency diary; QoL improvement. Continue PFMT long-term. Medication step-down if significant improvement (antimuscarinics 3–6 months).

Medication step-downQoL improvement

Annual review

Weight; anticholinergic burden (cognitive function in elderly) — OAB medicines reviewed annually, 6-monthly if over 75; ask about haematuria; prolapse progression; PHQ-9 if QoL still impaired.

Anticholinergic review

Post-surgical (if applicable)

Mid-urethral sling: voiding function; post-void residual; mesh complications (urgency, pain, erosion). NICE NG123: confirmed mesh complications are recorded in the national registry and reported to the MHRA (Yellow Card).

Mesh complications

7E — Safety-netting

⚠ Three scenario-specific phrases

Why safety-netting matters

Haematuria without suspected cancer pathway referral = missed bladder cancer = medicolegally indefensible; document safety-net in notes

Antimuscarinics without retention warning = prescribing safety gap; document counselling given

Cauda equina presenting as incontinence = missed emergency; safety-net documents neurological screening

PFMT: NICE NG123 advises a supervised trial of at least 3 months; document date started and progress at each review

Oxybutynin in >65: STOPP criteria; document cognitive and falls risk assessment

Mesh complications: MHRA mandates reporting all post-surgical mesh complications via Yellow Card

4 weeksBladder diary; medication response; PFMT adherence

3 monthsConservative treatment response; referral decision if no improvement

ImmediatelyHaematuria; acute retention; cauda equina symptoms; mesh complications

🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills

Closing phrases

"I'd like to start you on pelvic floor exercises today — 3 sets a day, 8–12 squeezes, hold for a count of 6."

"70–80% of women improve significantly without surgery — you don't have to put up with this."

"Blood in urine, even once → contact us same day."

"Can I ask if this has affected your sex life at all?"

"Review in 4 weeks. Any questions?"

Final deductions

Antimuscarinics without conservative treatment first (NICE NG123)
Antimuscarinics in elderly without checking retention / cognitive risk
No haematuria safety-net
Cauda equina not screened
Normalised as inevitable
Coital incontinence not asked

🔴 Red

Antimuscarinics without conservative Rx • haematuria missed • type not characterised • normalised as ageing • no ICE • no PFMT instructions

🟠 Amber

Type characterised • PFMT started • haematuria safety-net • QoL not fully explored • coital incontinence missed

🟢 Green

Type named • UTI excluded • PFMT instructed • haematuria safety-net • mirabegron in elderly • coital incontinence • ICE in plan • 4-week follow-up

"I've been meaning to come about this for ages but it's embarrassing. I leak when I cough or sneeze and sometimes I don't make it to the toilet in time. I've been using pads every day for over a year."

Who you are

Carol, 52, teacher. Two vaginal deliveries (second with forceps). Menopause 14 months ago. BMI 28. Drinks 5 cups of coffee daily. Non-smoker. Stopped Zumba 6 months ago due to leakage fear. Using 3–4 pads/day. No previous GP consultation about this.

Hidden agenda

Terrified of surgery (has heard about mesh complications). Leakage during sex — has avoided intimacy with husband for 4 months without explanation. Significantly depressed (PHQ-9 ~13) but won't volunteer this. No haematuria. No neurological symptoms.

If asked directly

Type: mixed (stress worse than urgency): "both, but the coughing and sneezing is definitely worse"
Coital incontinence: "yes actually... it's happened a few times and it's been really upsetting"
Mood: "honestly, it's really getting me down — I feel like I've lost my confidence"
No blood in urine; no saddle anaesthesia or leg weakness; no prolapse symptoms

Lifestyle

5 cups coffee/day (main fluid source); very little water
Stopped exercise 6 months ago
Has not tried pelvic floor exercises (didn't know where to start)
Husband unaware of severity

"I've heard about the mesh thing on the news — I really don't want surgery. Is there anything that doesn't involve an operation?"

Resolution: Accept the plan if the doctor: (1) Characterises the type as mixed (stress predominant); (2) Reassures about non-surgical options (≥70% improve with PFMT); (3) Asks about coital incontinence; (4) States haematuria safety-net explicitly; (5) Addresses coffee intake; (6) Explores mood; (7) Gives specific PFMT instructions; (8) Arranges 4-week follow-up.

🏥

Clinic Quick Reference

Urinary Incontinence — Clinical Decision Framework

NICE NG123 (2019)

▼expand

🚦 1 — Triage by Type

SUI — Stress

Cough/sneeze/exertion leakage • PFMT 3 months minimum • Continence physio if fails • Duloxetine if surgery declined • Mid-urethral sling if all fails

OAB — Urgency

Urgency ± frequency ± nocturia • Exclude UTI • Bladder retraining 6–8 weeks • Antimuscarinics or mirabegron (>65) • Botox / SNS if fails

Urgent / Emergency

Haematuria → suspected cancer pathway referral per NG12 (visible ≥45; non-visible ≥60 with dysuria/raised WCC) • Acute retention → same-day • Cauda equina → 999 MRI • Overflow → PVR in context, refer if persistent significant residual

📊 2 — Key Numbers

3 months

Conservative Rx before surgery

70–80%

SUI improvement with PFMT

75%

OAB improvement with retraining

3×/day

PFMT sets (8–12 contractions)

1.5–2L

Optimal fluid intake

>8 voids/day

Frequency: OAB criterion

No fixed cut-off

Post-void residual: interpret in context

Frail / older

Minimise anticholinergic burden; consider mirabegron

💊 3 — Drug Selection Quick Reference

🟢 OAB pharmacotherapy

First: antimuscarinic by local formulary (e.g. tolterodine 4mg XL OD or solifenacin 5mg OD) • Unsuitable, ineffective or not tolerated, or frail/high anticholinergic burden: mirabegron 50mg OD (check BP) or vibegron • Avoid: Oxybutynin IR in elderly (STOPP; cognitive + falls)

🔵 SUI / GSM pharmacotherapy

Duloxetine (Yentreve 40mg BD): SUI after PFMT failed + surgery declined only • Post-menopausal GSM: vaginal oestrogen is primary treatment for urgency + recurrent UTI • NOT systemic HRT for incontinence

🔴 Red flags: Haematuria (suspected cancer pathway) • Acute retention (A&E) • Cauda equina (999) • Overflow (PVR in context) • Pelvic mass with incontinence

🛡️ Safeguarding: Coital incontinence + abuse history (fistula?) • Depression/social withdrawal • Anticholinergics + cognitive decline in elderly • Pad dependency normalised without assessment

🎓

SCA Exam Quick Reference

SCA Consultation Blueprint

Tasks · Relating to Others · Global Skills · RAG guide

▼expand

🕐 12-Minute Consultation Flow

0–2 min

Normalise + open

"A lot of women deal with this but don't always feel comfortable talking about it — thank you for raising it."

ROGS

✗ "Is it worse when you cough?" first • ✗ "It's just part of getting older"

2–5 min

Type + haematuria

"Does it happen with coughing/sneezing or do you get a sudden urge first — or both?"

Characterise SUI vs OAB vs mixed. Ask haematuria. Fluid intake. Medications. Post-menopausal status.

TasksGS

✗ Not characterising type • ✗ Haematuria not asked

5–7 min

ICE + coital

"Has this affected your sex life? I ask everyone — it's common and treatable."

ICE: fear of surgery; embarrassment; fatalism. QoL: exercise stopped? social withdrawal?

ROGS

✗ No ICE • ✗ Coital incontinence not asked

7–10 min

Conservative plan

"Pelvic floor exercises 3 times a day — 8–12 squeezes each time. 70–80% improve without surgery."

PFMT for SUI; bladder retraining for OAB; UTI excluded; coffee reduction; bladder diary.

TasksRO

✗ Antimuscarinics without conservative Rx • ✗ No PFMT instructions

10–12 min

Safety-net + close

"Blood in urine → same-day contact. Review in 4 weeks. Anything else?"

Haematuria safety-net. Retention warning if medication. 4-week follow-up. Closing question.

TasksROGS

✗ No haematuria safety-net • ✗ No follow-up • ✗ No closing question

🔴🟠🟢 RAG Scoring

Tasks

🟢

Type characterised • UTI excluded • PFMT instructed • haematuria safety-net • mirabegron in elderly • 4-week follow-up

🟠

Type characterised • PFMT mentioned • haematuria safety-net • coital incontinence missed • no bladder diary

🔴

Type not characterised • antimuscarinics without conservative Rx • haematuria missed • overflow not considered

Relating to Others

🟢

Normalised empathetically • not fatalistic • ICE all 3 • coital incontinence • mood explored • shared decision

🔴

"Just ageing" comment • no ICE • coital incontinence missed • plan imposed • no mood

Global Skills

🟢

Normalised • jargon-free • 70–80% reassurance • timed • closing question

🔴

"Just ageing" • medical jargon • no summary • no closing question

💬 Key Phrases

Normalise

"A lot of women deal with this but don't always mention it — thank you for raising it."

Not inevitable

"You don't have to put up with this — 70–80% of women improve significantly."

Type Q

"Cough/sneeze leakage or sudden urge first — or both?"

Coital

"Has it affected your sex life? I ask everyone — it's very common and treatable."

PFMT

"3 sets of exercises a day, 8–12 squeezes, hold for a count of 6."

Safety-net

"Blood in urine → same-day contact. Review in 4 weeks."

🚫 9 Danger Zones

✗

Not characterising type (SUI vs OAB vs mixed)
→ "Cough/sneeze or urgent urge?" — must ask; determines entire treatment pathway

✗

Antimuscarinics without conservative treatment first
→ NICE NG123: bladder retraining minimum 6–8 weeks before pharmacotherapy

✗

Haematuria not asked or not escalated
→ Any haematuria = same-day contact; suspected cancer pathway referral per NG12 thresholds, urological/renal assessment otherwise; document in notes

✗

Normalising as "just part of ageing"
→ "You don't have to put up with this" — reframe scores RO marks

✗

Oxybutynin in elderly woman (>65)
→ STOPP criteria: cognitive impairment + falls; use another antimuscarinic or mirabegron, minimising anticholinergic burden

✗

Antimuscarinics for overflow incontinence
→ Catastrophic: worsens retention; check post-void residual if overflow features

✗

Coital incontinence not asked
→ Affects 30% of women with SUI/OAB; must ask directly — scores RO mark

✗

UTI not excluded before treating OAB
→ UTI is most common reversible cause of urgency; dipstick before antimuscarinics

✗

Cauda equina not screened in new-onset incontinence
→ New incontinence + saddle anaesthesia + leg weakness = 999 emergency MRI

Urinary Incontinence (Female) · GP Clinical Reasoning Framework v2 · NICE NG123 Urinary incontinence and pelvic organ prolapse in women (2019) · NICE NG12 Suspected cancer: recognition and referral (updated April 2026) · STOPP/START Criteria v3 (2023, international)

v2: Clinical stem · Open Q first · ICE in all modes · Psychosocial (1C + 7D) · Safeguarding · Expectation management (7A) · SCA RAG checkpoints after every step · SCA Scorecard · Dual summaries

Teaching clinicians why each step matters — not just what to do · Always consult current SPC and NICE NG123 · Clinical judgement takes precedence over any framework

Urinary Incontinence (Female)

Red Flags in female urinary incontinence

Safeguarding Considerations

👴 Domestic abuse and urinary incontinence

🧠 Mental health impact

👤 Older women and falls risk

🕊 Carer and dignity issues

👴 Social withdrawal and isolation

💉 Relationship and intimacy

📌 Pad use and cost

🧠 Fatalism: "it's just part of getting old"

999 / Same Day

Suspected cancer pathway referral / Urology

GP-managed

Stress Urinary Incontinence (SUI)

Overactive Bladder (OAB) / Urgency incontinence

Mixed incontinence

GSM-related incontinence

Pelvic organ prolapse + incontinence

Overflow incontinence (retention)

Cauda equina syndrome

Validate

Explain

Agree today's plan

4 weeks (early review)

3 months (NICE NG123 PFMT trial)

6 months (sustained response)

Annual review

Post-surgical (if applicable)

⚠ Three scenario-specific phrases

Why safety-netting matters

🎭 Patient actor brief — click to practise

Who you are

Hidden agenda

If asked directly

Lifestyle